SCHEMBL28483022

SCHEMBL28483022

NC(=O)OC1(c2ccnc(Cl)n2)CC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.30
▸ MAP4K4 O95819 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21410495 0.94 — —
SCHEMBL29974013 0.76 FLT4 (0.34) TRPV1MAP4K4
SCHEMBL23850569 0.76 FLT4 (0.34) TRPV1MAP4K4
SCHEMBL28475039 0.74 CTPS1 (0.44) —
SCHEMBL21410240 0.73 CTSK (0.35) —
SCHEMBL21410312 0.72 CTSK (0.36) —
SCHEMBL23754201 0.72 — —
SCHEMBL21381411 0.71 AKR1C1 (0.34) TRPV1MAP4K4
SCHEMBL21410336 0.71 — —
SCHEMBL28682801 0.71 FFAR4 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868051-B Aminopyrimidine derivatives as CTPS1 inhibitors 斯泰普制药股份公司 2024-04-09 — — CN disclosed
CN-114008039-B Compounds as human CTPS1 inhibitors for the treatment of proliferative diseases 斯泰普制药股份公司 2024-01-16 — — CN disclosed
CN-114008039-A N- (5- (6-ethoxypyrazin-2-yl) pyridin-2-yl) -4- (2- (methylsulfonylamino) pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases 斯泰普制药股份公司 2022-02-01 — — CN disclosed
CN-111868051-A Aminopyrimidine derivatives as CTPS1 inhibitors 斯泰普制药股份公司 2020-10-30 — — CN disclosed
Send feedback